CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Elisabeth-TweeSteden Ziekenhuis

Academic/HospitalWebsite ↗

Also known as: Elisabeth-TweeSteden Ziekenhuis | Elisabeth ziekenhuis

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Apr 1, 2023

Timeline

1980s

Jan 1, 1982
Elisabeth-TweeSteden Ziekenhuis— Founded

Drugs by trial phase (11 distinct, 7 trials)

Phase 4 (4 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

octreotide

Phase 2 (2 own, 0 via acquisition)

Other trials (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT06172010CollaboratorPhase 4Apr 1, 2023
NCT04481256CollaboratorN/AOct 1, 2020
NCT02054442CollaboratorPhase 1/Phase 2Aug 1, 2016
NCT02384122CollaboratorPhase 2/Phase 3Sep 1, 2015
NCT01139489CollaboratorN/ANov 30, 2009
NCT00758641CollaboratorPhase 4Sep 1, 2009
NCT00757289Overall official - principal investigatorN/AAug 1, 2007

Details

Founded: Tilburg, NL Jan 1, 1982
Last known activity: Apr 1, 2023